Literature DB >> 19117095

(15)N{(31)P} REDOR NMR studies of the binding of phosphonate reaction intermediate analogues to Saccharomyces cerevisiae lumazine synthase.

Tsyr-Yan Yu1, Robert D O'Connor, Astrid C Sivertsen, Colby Chiauzzi, Barbara Poliks, Markus Fischer, Adelbert Bacher, Ilka Haase, Mark Cushman, Jacob Schaefer.   

Abstract

Lumazine synthase catalyzes the reaction of 5-amino-6-D-ribitylamino-2,4(1H,3H)-pyrimidinedione(1) with (S)-3,4-dihydroxybutanone 4-phosphate (2) to afford 6,7-dimethyl-8-D-ribityllumazine(3), the immediate biosynthetic precursor of riboflavin. The overall reaction implies a series of intermediates that are incompletely understood. The 15N{31P} REDOR NMR spectra of three metabolically stable phosphonate reaction intermediate analogues complexed to Saccharomyces cereVisiae lumazine synthase have been obtained at 7 and 12 T. Distances from the phosphorus atoms of the ligands to the side chain nitrogens of Lys92, His97, Arg136, and His148 have been determined. These distances were used in combination with the X-ray crystal coordinates of one of the intermediate analogues complexed with the enzyme in a series of distance-restrained molecular dynamics simulations. The resulting models indicate mobility of the Lys92 side chain, which could facilitate the exchange of inorganic phosphate eliminated from the substrate in one reaction, with the organic phosphate-containing substrate necessary for the next reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19117095      PMCID: PMC2630582          DOI: 10.1021/bi8015789

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Riboflavin synthase of Escherichia coli. Effect of single amino acid substitutions on reaction rate and ligand binding properties.

Authors:  B Illarionov; K Kemter; S Eberhardt; G Richter; M Cushman; A Bacher
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

2.  Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.

Authors:  Muthusamy Jayaraman; Brian M Fox; Melinda Hollingshead; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

3.  A structure-based model of the reaction catalyzed by lumazine synthase from Aquifex aeolicus.

Authors:  Xiaofeng Zhang; Winfried Meining; Mark Cushman; Ilka Haase; Markus Fischer; Adelbert Bacher; Rudolf Ladenstein
Journal:  J Mol Biol       Date:  2003-04-18       Impact factor: 5.469

4.  A pentacyclic reaction intermediate of riboflavin synthase.

Authors:  B Illarionov; W Eisenreich; A Bacher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  [Isolation of riboflavin-deficient mutants of Saccharomyces cerevisiae].

Authors:  O Oltmanns; F Lingens
Journal:  Z Naturforsch B       Date:  1967-07       Impact factor: 1.047

6.  Studies on the reaction mechanism of riboflavin synthase: X-ray crystal structure of a complex with 6-carboxyethyl-7-oxo-8-ribityllumazine.

Authors:  Stefan Gerhardt; Ann-Kathrin Schott; Norman Kairies; Mark Cushman; Boris Illarionov; Wolfgang Eisenreich; Adelbert Bacher; Robert Huber; Stefan Steinbacher; Markus Fischer
Journal:  Structure       Date:  2002-10       Impact factor: 5.006

7.  Enzyme catalysis via control of activation entropy: site-directed mutagenesis of 6,7-dimethyl-8-ribityllumazine synthase.

Authors:  Markus Fischer; Ilka Haase; Klaus Kis; Winfried Meining; Rudolf Ladenstein; Mark Cushman; Nicholas Schramek; Robert Huber; Adelbert Bacher
Journal:  J Mol Biol       Date:  2003-02-21       Impact factor: 5.469

8.  [Riboflavin auxotrophs of Escherichia coli].

Authors:  S V Bandrin; M Iu Beburov; P M Rabinovich; A I Stepanov
Journal:  Genetika       Date:  1979-11

9.  Rotational-echo double-resonance NMR-restrained model of the ternary complex of 5-enolpyruvylshikimate-3-phosphate synthase.

Authors:  Lynda M McDowell; Barbara Poliks; Daniel R Studelska; Robert D O'Connor; Denise D Beusen; Jacob Schaefer
Journal:  J Biomol NMR       Date:  2004-01       Impact factor: 2.835

10.  Characterization of the complex of a trifluoromethyl-substituted shikimate-based bisubstrate inhibitor and 5-enolpyruvylshikimate-3-phosphate synthase by REDOR NMR.

Authors:  Lynda M McDowell; Daniel R Studelska; Barbara Poliks; R D O'Connor; Jacob Schaefer
Journal:  Biochemistry       Date:  2004-06-01       Impact factor: 3.162

View more
  5 in total

1.  31P-dephased, 13C-detected REDOR for NMR crystallography at natural isotopic abundance.

Authors:  Alexander I Greenwood; Mary C Clay; Chad M Rienstra
Journal:  J Magn Reson       Date:  2017-02-28       Impact factor: 2.229

2.  Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase.

Authors:  Arindam Talukdar; Ekaterina Morgunova; Jianxin Duan; Winfried Meining; Nicolas Foloppe; Lennart Nilsson; Adelbert Bacher; Boris Illarionov; Markus Fischer; Rudolf Ladenstein; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2010-04-08       Impact factor: 3.641

Review 3.  Bacterial cell wall composition and the influence of antibiotics by cell-wall and whole-cell NMR.

Authors:  Joseph A H Romaniuk; Lynette Cegelski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-05       Impact factor: 6.237

4.  O-Nucleoside, S-nucleoside, and N-nucleoside probes of lumazine synthase and riboflavin synthase.

Authors:  Arindam Talukdar; Yujie Zhao; Wei Lv; Adelbert Bacher; Boris Illarionov; Markus Fischer; Mark Cushman
Journal:  J Org Chem       Date:  2012-07-10       Impact factor: 4.354

5.  High Resolution 31P NMR Spectroscopy Generates a Quantitative Evolution Profile of Phosphorous Translocation in Germinating Sesame Seed.

Authors:  Honghao Cai; Wei-Gang Chuang; Xiaohong Cui; Ren-Hao Cheng; Kuohsun Chiu; Zhong Chen; Shangwu Ding
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.